Sleep SMARTNCT03812653
Sleep for Stroke Management and Recovery Trial
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 36 versions: 35 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Study sites: 116 to 148
Notable Eligibility criteria expanded, about 18 words Show 6 more changesShow less
- Trial completed
- Final enrollment: 1892 participants (planned 3062)
- Primary completion date changed from estimate of Nov 2026 to Jul 8, 2026
- Secondary endpoints: details revised at 3 of 3 entries
- Site details revised at 8 of 116 sites
- Publications: details revised at 2 of 2 entries
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised at 116 of 116 sites
- Minor Site details revised at 4 of 116 sitesv32
- Minor Site details revised at 8 of 116 sitesv31
Show 29 earlier versionsHide 29 earlier versions
- Minor Site details revised at 13 of 116 sitesv30
- Minor Site details revised at 14 of 116 sitesv29
- Minor Site details revised at 19 of 116 sitesv28
- Minor Study sites: 112 to 116v27
- Minor Site details revised at 107 of 112 sitesv26
- Minor Study sites: 110 to 112v25
- Minor Study sites: 111 to 110v24
- Notable Eligibility criteria expanded, about 30 words
- Study sites: 112 to 111
- Minor Site details revised at 5 of 112 sitesv22
- Minor Study sites: 110 to 112v21
- Minor Study sites: 111 to 110v20
- Minor Study sites: 109 to 111v19
- Minor Site contacts updated at 4 of 109 sitesv18
- Minor Study sites: 110 to 109v17
- Notable Primary and study completion dates: Nov 2023 to Nov 2026
- Study sites: 112 to 110
- Minor Study sites: 113 to 112v15
- Minor Study sites: 115 to 113v14
- Minor Study sites: 120 to 115v13
- Minor Study sites: 121 to 120v12
- Minor Study sites: 124 to 121v11
- Minor Study sites: 125 to 124v10
- Minor Study sites: 121 to 125v9
- Notable Trial status: Suspended to Recruiting
- Site details revised at 121 of 121 sites
- Stopped Trial status: Recruiting to Suspended Sponsor's reason: Stopped until further notice due to COVID-19 restrictions
- Study sites: 114 to 121
- Minor Study sites: 107 to 114v6
- Minor Study sites: 106 to 107v5
- Minor Study sites: 103 to 106v4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Eligibility criteria expanded, about 5 words
- Study sites: 106 to 103
- Start date changed from estimate of May 2019 to May 9, 2019
- Notable Start date: Mar 2019 to May 2019v2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Time to Event Combined Outcome: new ischemic stroke, acute coronary syndrome, or all-cause mortality
Timeframe: 6 months post randomization
Modified Rankin Scale Score
Timeframe: 3 months post randomization
Secondary (3)
NIH Stroke Score (NIHSS)
Short Montreal Cognitive Assessment (MoCA) Score
Quality of Life outcome
Arms and interventions
Intervention Arm: CPAP with Usual Care.Experimental
6 months of CPAP plus usual medical therapy.
Control Arm: Usual Care.No intervention
6 months of usual medical therapy alone.
Devices: CPAP
Sites
148 sites in 1 country